Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative.

Area of Science:

• Pharmacoepidemiology and Health Services Research

Background:

• Drug plan managers require real-world evidence on drug safety, effectiveness, and policy impact.
• University researchers can provide this evidence using administrative health data.
• Collaborations can leverage variations in drug coverage policies across health plans.

Purpose of the Study:

• To describe the initial experience of collaborating with drug plan managers and researchers in Canada.
• To explore the use of population-based health data for real-world evidence generation.
• To facilitate research on drug safety, effectiveness, and policy in universal healthcare systems.

Main Methods:

• Collaboration between university-based pharmacoepidemiologists and drug plan managers.
• Utilizing population-based, linked administrative health care databases.
• Leveraging universal health insurance and public drug benefit plans in Canada.

Main Results:

• Initial experiences in establishing research collaborations in British Columbia and Ontario are described.
• Demonstrated feasibility of using Canadian health data for pharmacoepidemiological research.
• Identified opportunities for studying drug plan policy variations.

Conclusions:

• Canada's healthcare system provides an ideal setting for real-world evidence research.
• Collaboration between researchers and drug plan managers is crucial for generating actionable insights.
• This approach can inform drug safety, effectiveness, and policy decisions.